Operative mortality with implantation of the automatic cardioverter-defibrillator

The American Journal of Cardiology

Volumn 68, Issue 13, 1991, Pages 1340-1345

  Mosteller, Robert D ^a,b   Lehmann, Michael H ^a,b   Thomas, Andra C ^a,b   Jackson, Kenneth ^a,b   Participating Investigators, ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; MALE; PRIORITY JOURNAL; SURGICAL MORTALITY;

COHORT STUDIES; DEATH, SUDDEN, CARDIAC; ELECTRIC COUNTERSHOCK; FEMALE; HOSPITAL MORTALITY; HUMAN; MALE; MIDDLE AGE; PROSTHESES AND IMPLANTS; RISK FACTORS; STROKE VOLUME; TACHYCARDIA; THORACOTOMY; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 0025787648     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(91)90242-D     Document Type: Article

References (23)

1. Results of device therapy in high risk patients:504–507
2. When “sudden cardiac death” is not so sudden: lessons learned from the automatic implantable defibrillator
3. The automatic implantable cardioverter-defibrillator: clinical experience, complications, and follow-up in 25 patients
4. The automatic Implantable cardioverter-defibrillator: efficacy, complications, and device failures
5. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias
6. The automatic implantable cardioverter-defibrillator; efficacy, complications and survival in patients with malignant ventricular arrhythmias
7. Long-term outcome with the automatic implantable cardioverter-defibrillator
8. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator
9. Follow-up of patients with ventricular tachyarrhythmia treated with the automatic implantable cardioverter defibrillator: programmed electrical stimulation results do not predict clinical outcome
10. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator
11. Occurrence of ICD shocks and patient survival
12. Long-term community hospital experience with the internal defibrillator
13. Determinants of operative mortality in implantable cardioverter defibrillators (abstr)
14. Prophylactic automatic implantable cardioverter-defibrillator patches in patients at high risk for postoperative ventricular tachyarrhythmias
15. Defibrillation threshold testing and other practices related to AICD implantation: do all roads lead to Rome?
16. Effect of epicardial patch electrodes on transthoracic defibrillation
17. Mechanisms and risk factors far proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy
18. Amiodarone-induced refractoriness to cardioversion
19. The implanted defibrillator: relation of defibrillating lead configuration and clinical variables to defibrillation threshold
20. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs: sodium channel block and action potential prolongation
21. Implantable cardioverter defibrillators in cardiovascular practice: report of the policy conference of the North American Society of Pacing and Electrophysiology
22. Implantable cardioverter/defibrillator — the potential hazard of programmability (abstr)
23. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system